Circulating endothelial cells are associated with thromboembolic events in patients with antiphospholipid antibodies.
Fiche publication
Date publication
août 2022
Journal
Thrombosis and haemostasis
Auteurs
Membres identifiés du Cancéropôle Est :
Pr FAURE Gilbert
Tous les auteurs :
Foret T, Dufrost V, Heymonet M, Risse J, Faure G, Louis H, Lagrange J, Lacolley P, Devreese KMJ, Gibot S, Regnault V, Zuily S, Wahl D
Lien Pubmed
Résumé
Endothelium damage has been described in antiphospholipid antibodies (aPL) positive patients. However, it is uncertain whether circulating endothelial cells (CECs) - which are released when endothelial injury occurs - can identify patients at high risk for thrombosis.
Référence
Thromb Haemost. 2022 08 17;: